ARCHIVES

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

This article is from The Cancer Letter archive.

Vol. 39 No. 40 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

The Meeting At the Beverly Hills Suite: Salick, Zeneca Par Way Acrimoniously

May 2, 1997

ASCO Members asked To Help In Planning

August 26, 1988

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

Funding opportunities listed.

October 8, 2004

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977